Information for Timeline of incretin therapeutics
Page information·measured at build time
Technical and provenance information about Timeline of incretin therapeutics. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Timeline of incretin therapeutics |
|---|---|
| Default sort key | Timeline of incretin therapeutics |
| Namespace | Article (main) |
| Page kind | List |
| Page length (source, bytes) | 4,460 |
| Rendered word count | 458 |
| Internal wiki links on the page | 30 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 3 |
| Figures | 0 |
| Infobox | Yes — list |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | ComparisonCato |
|---|---|
| Date of page creation | 19 July 2024 |
| Latest editor | OrforglipronOona |
| Date of latest edit | 16 July 2026 |
| Total number of edits | 30 |
| Total number of distinct authors | 25 |
| Minor edits | 9 |
| Automated (bot) edits | 1 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 4 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| INN_Ingrid | 2 | 6.7% | GLP-1 receptor agonists and related compounds |
| ExenatideEzra | 2 | 6.7% | GLP-1 receptor agonists and related compounds |
| SurvodutideSaff | 2 | 6.7% | GLP-1 receptor agonists and related compounds |
| OrforglipronOona | 2 | 6.7% | GLP-1 receptor agonists and related compounds |
| AnalyticalAnnie | 2 | 6.7% | analytical chemistry and chromatography |
| ComparisonCato | 1 | 3.3% | GLP-1 receptor agonists and related compounds |
| TirzTaxonomist | 1 | 3.3% | GLP-1 receptor agonists and related compounds |
| Chromatokid | 1 | 3.3% | analytical chemistry and chromatography |
| TriumphThad | 1 | 3.3% | clinical trials and evidence appraisal |
| StopperingSteff | 1 | 3.3% | peptide synthesis and supply chain |
| PeakShapePol | 1 | 3.3% | analytical chemistry and chromatography |
| DulaglutideDug | 1 | 3.3% | GLP-1 receptor agonists and related compounds |
Category membership
- Category:Timelines — 1 member pages
- Category:Reference material — 4 member pages
- Category:Clinical evidence — 11 member pages